SCHEMBL25565952

SCHEMBL25565952

CCc1cnc(C(=O)NC)nc1-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BAZ2B Q9UIF8 1/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.43
▸ ALDH1A1 P00352 6/20 0.41
▸ CHEK1 O14757 1/20 0.41
▸ RET P07949 1/20 0.41
▸ PDGFRB P09619 1/20 0.41
▸ PIM1 P11309 1/20 0.41
▸ PDGFRA P16234 1/20 0.41
▸ GSK3B P49841 1/20 0.41
▸ RPS6KA3 P51812 1/20 0.41
▸ LIMK1 P53667 1/20 0.41
▸ CDK5 Q00535 1/20 0.41
▸ TYRO3 Q06418 1/20 0.41
▸ MAPK14 Q16539 1/20 0.41
▸ LRRK2 Q5S007 1/20 0.41
▸ AURKB Q96GD4 1/20 0.41
▸ CLK4 Q9HAZ1 1/20 0.41
▸ DYRK1B Q9Y463 1/20 0.41
▸ HPGD P15428 3/20 0.40
▸ BRD4 O60885 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25551902 0.73 DHODH (0.40) ALDH1A1HPGDKDM4ENPC1RAB9A
SCHEMBL25551932 0.72 ALDH1A1 (0.56) ALDH1A1HPGDKDM4EGAALMNA
SCHEMBL30036948 0.72 ALDH1A1 (0.56) ALDH1A1HPGDKDM4EGAALMNA
SCHEMBL25551910 0.72 ALDH1A1 (0.56) ALDH1A1GAALMNAMAPTMAPK1
SCHEMBL30268103 0.72 ADORA1 (0.53) ALDH1A1GAALMNAMAPT
SCHEMBL15156679 0.72 ADORA1 (0.53) ALDH1A1GAALMNAMAPT
SCHEMBL25559540 0.69 PPARG (0.41) CNR1
SCHEMBL30309907 0.69 PLK1 (0.43) BAZ2BALDH1A1HPGDKDM4ENPC1
SCHEMBL25560591 0.69 PDK1 (0.36) ALDH1A1NPC1RAB9ANTRK1LMNA
Hydrochloric Acid SCHEMBL14842833 0.68 PLK1 (0.42) BAZ2BALDH1A1HPGDKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159508-A1 INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159508-A1 INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE RIPK1, RIPK2, RIPK4 BAZ2B 996/4885NPSR1 3509/4885ALDH1A1 4554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback